Akebia Ther
Drug Manufacturers - Specialty & Generic
Healthcare
AKBA
210 M shares
NASDAQ US
traded
25 Jun 2025
listed
no
open
3.65
52 week high
3.97
high
3.79
52 week low
1.28
low
3.56
growth
152.05 %
previous Close
3.67
P/E ratio
market cap
404 M
div yield
0
usd
Sep 2024
qoq
revenue
37.43 M
-14.25 %
net incoming
-20.04 M
-133.50 %
eps
0.00 %
-150.00 %
eps surprise
-66.67 %
net profit margin
-53.54 %
-33.00 %
operating incoming
-12.51 M
-43.32 %
net change in cash
-3.81 M
-54.59 %
cash on hand
34.02 M
-13.87 %
cost of revenue
14.16 M
-18.83 %
top top